FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1836400534> ?p ?o ?g. }

• W1836400534 endingPage "697" @default.
• W1836400534 startingPage "690" @default.
• W1836400534 abstract "PURPOSE Since the only three cases of granulocytic sarcoma among patients with acute myeloid leukemia (AML) seen at our institution during the last 12 years were each associated with the 8;21 translocation [t(8;21)], we sought to determine if this association is specific and more frequent than previously recognized. PATIENTS AND METHODS We report three patients with AML and t(8;21) who developed granulocytic sarcomas, and review the world literature. RESULTS Between 1980 and 1992, 53 cases of AML French-American-British (FAB) M2 were identified at our institution. Eight (15%) patients had t(8;21). Three of these eight patients (38%) developed granulocytic sarcoma. All three of our patients received conventional intensive antileukemic chemotherapy yet had short relapse-free survival durations. Several series of patients with t(8;21) report that granulocytic sarcomas occur in approximately 18% of this population, which is four times the expected incidence in AML. Thirty-seven cases have been previously reported. Although karyotype analyses were not reported in many cases of granulocytic sarcoma in the literature, the vast majority of abnormal karyotypes in patients with AML involved t(8;21). Recent work with a cell line derived from a patient with t(8;21) indicates that such cells are unusually adherent to culture bottles and are aggregable CONCLUSION Our data suggest that this association is more common than generally recognized and may be specific. Patients with t(8;21) should be observed closely for signs and symptoms of granulocytic sarcoma. These patients may have a less favorable prognosis than other patients with t(8;21). Cooperative oncology groups should retrospectively identify patients with AML and t(8;21) who had a poor outcome to determine if they had a disproportionate incidence of granulocytic sarcoma. If so, aggressive therapy such as bone marrow transplantation may be warranted early in the therapeutic strategy." @default.
• W1836400534 created "2016-06-24" @default.
• W1836400534 creator A5001124933 @default.
• W1836400534 creator A5004384259 @default.
• W1836400534 creator A5050132420 @default.
• W1836400534 creator A5083784159 @default.
• W1836400534 creator A5087705903 @default.
• W1836400534 creator A5090334765 @default.
• W1836400534 date "1993-04-01" @default.
• W1836400534 modified "2023-09-30" @default.
• W1836400534 title "Granulocytic sarcoma is associated with the 8;21 translocation in acute myeloid leukemia." @default.
• W1836400534 cites W110083684 @default.
• W1836400534 cites W1540357669 @default.
• W1836400534 cites W1544227046 @default.
• W1836400534 cites W1547750687 @default.
• W1836400534 cites W162620296 @default.
• W1836400534 cites W1967607135 @default.
• W1836400534 cites W1971313638 @default.
• W1836400534 cites W1975019401 @default.
• W1836400534 cites W1977537396 @default.
• W1836400534 cites W1978636076 @default.
• W1836400534 cites W1981848839 @default.
• W1836400534 cites W1983698235 @default.
• W1836400534 cites W1991080560 @default.
• W1836400534 cites W1996076369 @default.
• W1836400534 cites W1998258339 @default.
• W1836400534 cites W2000877675 @default.
• W1836400534 cites W2001047420 @default.
• W1836400534 cites W2001323814 @default.
• W1836400534 cites W2013060018 @default.
• W1836400534 cites W2013084492 @default.
• W1836400534 cites W2026088969 @default.
• W1836400534 cites W2027803588 @default.
• W1836400534 cites W2034773218 @default.
• W1836400534 cites W2036536579 @default.
• W1836400534 cites W2043189316 @default.
• W1836400534 cites W2045671785 @default.
• W1836400534 cites W2048093335 @default.
• W1836400534 cites W2054834169 @default.
• W1836400534 cites W2062958138 @default.
• W1836400534 cites W2063757021 @default.
• W1836400534 cites W2065529064 @default.
• W1836400534 cites W2068728784 @default.
• W1836400534 cites W2072205684 @default.
• W1836400534 cites W2076426515 @default.
• W1836400534 cites W2084009934 @default.
• W1836400534 cites W2122577451 @default.
• W1836400534 cites W2136760687 @default.
• W1836400534 cites W2161037099 @default.
• W1836400534 cites W2169699456 @default.
• W1836400534 cites W2235135682 @default.
• W1836400534 cites W2275297360 @default.
• W1836400534 cites W2301627870 @default.
• W1836400534 cites W2316726335 @default.
• W1836400534 cites W2329719313 @default.
• W1836400534 cites W2333326790 @default.
• W1836400534 cites W2411922891 @default.
• W1836400534 cites W2415127860 @default.
• W1836400534 cites W2416309276 @default.
• W1836400534 cites W2437945164 @default.
• W1836400534 cites W2439317184 @default.
• W1836400534 cites W283165560 @default.
• W1836400534 cites W296976531 @default.
• W1836400534 cites W3113814835 @default.
• W1836400534 doi "https://doi.org/10.1200/jco.1993.11.4.690" @default.
• W1836400534 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8478662" @default.
• W1836400534 hasPublicationYear "1993" @default.
• W1836400534 type Work @default.
• W1836400534 sameAs 1836400534 @default.
• W1836400534 citedByCount "217" @default.
• W1836400534 countsByYear W18364005342012 @default.
• W1836400534 countsByYear W18364005342013 @default.
• W1836400534 countsByYear W18364005342014 @default.
• W1836400534 countsByYear W18364005342015 @default.
• W1836400534 countsByYear W18364005342016 @default.
• W1836400534 countsByYear W18364005342017 @default.
• W1836400534 countsByYear W18364005342018 @default.
• W1836400534 countsByYear W18364005342019 @default.
• W1836400534 countsByYear W18364005342020 @default.
• W1836400534 countsByYear W18364005342021 @default.
• W1836400534 countsByYear W18364005342022 @default.
• W1836400534 countsByYear W18364005342023 @default.
• W1836400534 crossrefType "journal-article" @default.
• W1836400534 hasAuthorship W1836400534A5001124933 @default.
• W1836400534 hasAuthorship W1836400534A5004384259 @default.
• W1836400534 hasAuthorship W1836400534A5050132420 @default.
• W1836400534 hasAuthorship W1836400534A5083784159 @default.
• W1836400534 hasAuthorship W1836400534A5087705903 @default.
• W1836400534 hasAuthorship W1836400534A5090334765 @default.
• W1836400534 hasConcept C104317684 @default.
• W1836400534 hasConcept C120665830 @default.
• W1836400534 hasConcept C121332964 @default.
• W1836400534 hasConcept C126322002 @default.
• W1836400534 hasConcept C138626823 @default.
• W1836400534 hasConcept C142724271 @default.
• W1836400534 hasConcept C143998085 @default.
• W1836400534 hasConcept C2776694085 @default.
• W1836400534 hasConcept C2778256501 @default.

• next